A detailed history of Mcintyre Freedman & Flynn Investment Advisers Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mcintyre Freedman & Flynn Investment Advisers Inc holds 6,052 shares of BMY stock, worth $348,474. This represents 0.22% of its overall portfolio holdings.

Number of Shares
6,052
Previous 7,052 14.18%
Holding current value
$348,474
Previous $293 Million 6.93%
% of portfolio
0.22%
Previous 0.21%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $39,660 - $51,750
-1,000 Reduced 14.18%
6,052 $313 Million
Q2 2024

Aug 08, 2024

BUY
$40.25 - $52.99 $283,843 - $373,685
7,052 New
7,052 $293 Million
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $57,890 - $64,730
1,000 Added 14.18%
8,051 $467 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $57,339 - $63,665
900 Added 14.63%
7,051 $451 Million
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $72,281 - $81,983
1,100 Added 21.78%
6,151 $426 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $345,892 - $409,585
5,051 New
5,051 $363 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mcintyre Freedman & Flynn Investment Advisers Inc Portfolio

Follow Mcintyre Freedman & Flynn Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcintyre Freedman & Flynn Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcintyre Freedman & Flynn Investment Advisers Inc with notifications on news.